ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-5.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$111M
AUM Growth
+$111M
(+44%)
Cap. Flow
+$36.6M
Cap. Flow
% of AUM
32.88%
Top 10 Holdings %
Top 10 Hldgs %
57.45%
Holding
58
New
25
Increased
8
Reduced
9
Closed
12
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$12M |
| 2 |
Thermo Fisher Scientific
TMO
|
$7.01M |
| 3 |
Bruker
BRKR
|
$5.98M |
| 4 |
Avantor
AVTR
|
$4.78M |
| 5 |
CONMED
CNMD
|
$4.23M |
Top Sells
| 1 |
Labcorp
LH
|
$7.86M |
| 2 |
Cigna
CI
|
$5.65M |
| 3 |
Agilent Technologies
A
|
$5.5M |
| 4 |
Becton Dickinson
BDX
|
$3.53M |
| 5 |
Cardinal Health
CAH
|
$3M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Real Estate | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insulet
PODD
$24.2B
| $1.42M | 1.27% |
+8,878
| New | +$1.42M |
|
27
89bio
ETNB
$1.37B
| $1.27M | 1.14% |
82,153
+52,871
| +181% | +$816K |
|
28
Hologic
HOLX
$14.7B
| $1.23M | 1.11% |
+17,750
| New | +$1.23M |
|
29
Ocular Therapeutix
OCUL
$2.25B
| $1.11M | 1% |
353,707
-14,731
| -4% | -$46.3K |
|
30
Azenta
AZTA
$1.35B
| $975K | 0.88% |
+19,422
| New | +$975K |
|
31
Tarsus Pharmaceuticals
TARS
$2.44B
| $847K | 0.76% |
+47,649
| New | +$847K |
|
32
AdaptHealth
AHCO
$1.23B
| $818K | 0.74% |
+89,937
| New | +$818K |
|
33
Axsome Therapeutics
AXSM
$6.09B
| $787K | 0.71% |
+11,254
| New | +$787K |
|
34
IQVIA
IQV
$31.4B
| $776K | 0.7% |
3,946
-15,223
| -79% | -$3M |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| $765K | 0.69% |
251,785
-29,656
| -11% | -$90.2K |
|
36
Olema Pharmaceuticals
OLMA
$432M
| $723K | 0.65% |
58,573
+18,389
| +46% | +$227K |
|
37
Ventyx Biosciences
VTYX
$184M
| $641K | 0.58% |
+18,458
| New | +$641K |
|
38
Arcellx
ACLX
$3.95B
| $508K | 0.46% |
+14,158
| New | +$508K |
|
39
GoodRx Holdings
GDRX
$1.49B
| $491K | 0.44% |
+87,290
| New | +$491K |
|
40
Cartesian Therapeutics
RNAC
$267M
| $481K | 0.43% |
453,314
-232,829
| -34% | -$247K |
|
41
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $302K | 0.27% |
+3,400
| New | +$302K |
|
42
Envista
NVST
$3.37B
| $301K | 0.27% |
+10,787
| New | +$301K |
|
|
ADAP
43
Adaptimmune Therapeutics
ADAP
$13.9M
| $243K | 0.22% |
311,944
-509,094
| -62% | -$397K |
|
|
44
Agilent Technologies
A
$35.5B
| – | – |
-45,762
| Closed | -$5.5M |
|
45
Acadia Healthcare
ACHC
$2.15B
| – | – |
-9,153
| Closed | -$729K |
|
|
46
Becton Dickinson
BDX
$54.3B
| – | – |
-13,360
| Closed | -$3.53M |
|
47
BioXcel Therapeutics
BTAI
$52.7M
| – | – |
0
| – | – |
|
|
48
Cardinal Health
CAH
$36B
| – | – |
-31,696
| Closed | -$3M |
|
49
Encompass Health
EHC
$12.5B
| – | – |
-32,710
| Closed | -$2.21M |
|
|
50
Labcorp
LH
$22.8B
| – | – |
-32,569
| Closed | -$7.86M |
|